Fibrobiologics

IN THE PRESS

Press Releases

FibroBiologics Files Patent Application for a Cell-based Therapeutic for the Treatment Of Splenomegaly

November 20, 2024

·

4 min read

Press Releases

FibroBiologics Files Patent Application Covering Reduction of Blood Clots Associated with Instant Blood-Mediated Inflammatory Reaction (IBMIR) in Cell-Based Therapeutics

November 14, 2024

·

4 min read

Press Releases

FibroBiologics Reports Third Quarter 2024 Financial Results and Provides Corporate Update

November 13, 2024

·

7 min read

Press Releases

FibroBiologics Announces Updates for Novel Artificial Thymus Organoid Technology

October 29, 2024

·

5 min read

Press Releases

FibroBiologics to Present at the 2024 ThinkEquity Conference and BIO-Europe 2024

October 28, 2024

·

1 min read

News

FibroBiologics and Charles River Announce Collaboration to Manufacture Fibroblast Cell-based Therapies for Chronic Diseases

October 18, 2024

·

5 min read

Press Releases

FibroBiologics Issued Patent for Fibroblast Delivery of Tumor Inhibitory Agents by the European Patent Office

October 17, 2024

·

4 min read

Business

FibroBiologics to Participate in a Fireside Chat at 2024 Maxim Healthcare Virtual Summit

October 11, 2024

·

1 min read

Business

FibroBiologics to Present at 2024 Cell & Gene Meeting on the Mesa

September 30, 2024

·

3 min read

Press Releases

FibroBiologics Engages Southern Star Research as CRO in Australia

September 20, 2024

·

5 min read

JOBS